104 related articles for article (PubMed ID: 6589043)
1. Altered 5-phosphoribosyl 1-pyrophosphate amidotransferase activity in 6-thioguanine-resistant HL-60 human acute promyelocytic leukemia cells.
Ishiguro K; Sartorelli AC
Cancer Res; 1984 Sep; 44(9):3679-85. PubMed ID: 6589043
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic and cytodifferentiative components of 6-thioguanine resistance in HL-60 cells containing acquired double minute chromosomes.
Gallagher RE; Ferrari AC; Zulich AW; Yen RW; Testa JR
Cancer Res; 1984 Jun; 44(6):2642-53. PubMed ID: 6586289
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the metabolic forms of 6-thioguanine responsible for cytotoxicity and induction of differentiation of HL-60 acute promyelocytic leukemia cells.
Ishiguro K; Schwartz EL; Sartorelli AC
J Cell Physiol; 1984 Nov; 121(2):383-90. PubMed ID: 6593322
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of the differentiation-inducing properties of 6-thioguanine by hypoxanthine and its nucleosides in HL-60 promyelocytic leukemia cells.
Ishiguro K; Sartorelli AC
Cancer Res; 1985 Jan; 45(1):91-5. PubMed ID: 3855287
[TBL] [Abstract][Full Text] [Related]
5. Modulation of 6-thioguanine activity by guanine in human promyelocytic leukemia HL-60 cells.
Cheng HW; Armstrong RD; Sadée W
Cancer Res; 1988 Jul; 48(13):3648-51. PubMed ID: 3163939
[TBL] [Abstract][Full Text] [Related]
6. Increased PRPP synthetase activity in cultured rat hepatoma cells containing mutations in the hypoxanthine-guanine phosphoribosyltransferase gene.
Graf LH; McRoberts JA; Harrison TM; Martin DW
J Cell Physiol; 1976 Jul; 88(3):331-42. PubMed ID: 178676
[TBL] [Abstract][Full Text] [Related]
7. Rat liver glutamine 5-phosphoribosyl-1-pyrophosphate amidotransferase [EC 2.4.2.14]. Purification and properties.
Tsuda M; Katunuma N; Weber G
J Biochem; 1979 May; 85(5):1347-54. PubMed ID: 447621
[TBL] [Abstract][Full Text] [Related]
8. [Purine metabolism: determination of PRPP-amidotransferase and PRPP-synthetase in lymphocytes from patients with chronic lymphatic leukemia (CLL)].
Tabucchi A; Terzuoli L; Di Stefano A; Pizzichini M; Leoncini R; Dispensa E; Marinello E
Boll Soc Ital Biol Sper; 1989 Nov; 65(11):1097-103. PubMed ID: 2560926
[TBL] [Abstract][Full Text] [Related]
9. Modulation of thiopurine cytotoxicity in the HL-60 cell line by physiological concentrations of hypoxanthine.
Zimm S; Johnson GE; Poplack DG
Cancer Res; 1986 Dec; 46(12 Pt 1):6286-9. PubMed ID: 3465436
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle events associated with the termination of proliferation by cytotoxic and differentiation-inducing actions of 6-thioguanine on HL-60 cells.
Schwartz EL; Blair OC; Sartorelli AC
Cancer Res; 1984 Sep; 44(9):3907-10. PubMed ID: 6589046
[TBL] [Abstract][Full Text] [Related]
11. [Properties of 5-phosphoryl-1-pyrophosphate amidotransferase from the yeast Saccharomyces cerevisiae wild type and mutant with altered purine biosynthesis regulation].
Smolina VS; Bekker ML
Biokhimiia; 1982 Jan; 47(1):162-7. PubMed ID: 7039693
[TBL] [Abstract][Full Text] [Related]
12. Molecular and biochemical mechanisms of fludarabine and cladribine resistance in a human promyelocytic cell line.
Månsson E; Spasokoukotskaja T; Sällström J; Eriksson S; Albertioni F
Cancer Res; 1999 Dec; 59(23):5956-63. PubMed ID: 10606241
[TBL] [Abstract][Full Text] [Related]
13. IMP dehydrogenase basal activity in MOLT-4 human leukaemia cells is altered by mycophenolic acid and 6-thioguanosine.
Vethe NT; Bremer S; Bergan S
Scand J Clin Lab Invest; 2008; 68(4):277-85. PubMed ID: 18609073
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of 6-mercaptopurine in human leukemic cells.
Higuchi T; Nakamura T; Wakisaka G
Cancer Res; 1976 Oct; 36(10):3779-83. PubMed ID: 821607
[TBL] [Abstract][Full Text] [Related]
15. Alterations in the topoisomerase II alpha gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase II beta enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line.
Harker WG; Slade DL; Parr RL; Feldhoff PW; Sullivan DM; Holguin MH
Cancer Res; 1995 Apr; 55(8):1707-16. PubMed ID: 7712479
[TBL] [Abstract][Full Text] [Related]
16. Biochemical parameters of mercaptopurine activity in patients with acute lymphoblastic leukemia.
Zimm S; Reaman G; Murphy RF; Poplack DG
Cancer Res; 1986 Mar; 46(3):1495-8. PubMed ID: 2417705
[TBL] [Abstract][Full Text] [Related]
17. Effect of uridine on response of 5-azacytidine-resistant human leukemic cells to inhibitors of de novo pyrimidine synthesis.
Grant S; Bhalla K; Gleyzer M
Cancer Res; 1984 Dec; 44(12 Pt 1):5505-10. PubMed ID: 6208998
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of phosphoribosylation of 5-fluorouracil by purines.
Yoshida M; Hoshi A; Kuretani K
Nucleic Acids Symp Ser; 1980; (8):s175-8. PubMed ID: 6789308
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of 5-phosphoribosyl-1-pyrophosphate synthetase by the monophosphate metabolite of 4-amino-8-(beta-D-ribofuranosylamino)pyrimido[5,4-d]pyrimidine: a novel mechanism for antitumor activity.
Fry DW; Boritzki TJ; Jackson RC; Cook PD; Leopold WR
Mol Pharmacol; 1993 Aug; 44(2):479-85. PubMed ID: 7689145
[TBL] [Abstract][Full Text] [Related]
20. The role of benzodiazepine receptors in the induction of differentiation of HL-60 leukemia cells by benzodiazepines and purines.
Ishiguro K; Taft WC; DeLorenzo RJ; Sartorelli AC
J Cell Physiol; 1987 May; 131(2):226-34. PubMed ID: 3034922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
